Certified by Founder Lodge
Foresite Capital
United States - Larkspur, California
INVESTOR
1 Disclosed Funding Rounds $30,000,000
15 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~ $3.5B in assets under management (as of 3/31/22). The firm aims to address areas of great unmet need by f
Company | Date | Round | Raised |
---|---|---|---|
Element Biosciences | July, 12 ,2024 | Series D | $277,000,000 |
FOLX Health | October, 17 ,2022 | Series B | $30,000,000 |
Delfi Diagnostics | July, 18 ,2022 | Series B | $225,000,000 |
Evonetix Ltd | February, 10 ,2023 | Series B | $24,000,000 |
DNAnexus | June, 09 ,2022 | Unknown | $100,000,000 |
Mirvie | May, 17 ,2022 | Series B | $60,000,000 |
Foresight Diagnostics Inc. | April, 28 ,2023 | Series B | $58,750,000 |
Thyme Care | August, 22 ,2023 | Series B | $60,000,000 |
Odyssey Therapeutics | December, 06 ,2023 | Series C | $101,000,000 |
Remix Therapeutics | January, 04 ,2024 | Unknown | $60,000,000 |
Latigo Biotherapeutics, Inc. | February, 15 ,2024 | Series A | $135,000,000 |
FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
Alumis | March, 07 ,2024 | Series C | $259,000,000 |
Element Biosciences | July, 12 ,2024 | Series D | $277,000,000 |
Candid Therapeutics | September, 10 ,2024 | Unknown | $370,000,000 |